Notes / Company

Bliss GVS Pharma Ltd.

BLISSGVS BSE 506197 ISIN INE416D01022 Pharmaceuticals

Fundamentals

Market cap: ₹3,177 cr
P/E: 24.61×
ROE: 8.03%
Debt / equity: 0.07
Div yield: 0.33%
52-week range: 118.00 — 304.00

Research on Tijori Finance

The timeline — 1 note on Bliss GVS Pharma Ltd.

May 2026

23 May 26 · 10:39 PM IST Alert

Alert · M&A

Anupam Rasayan buys 43% of Bliss GVS Pharma in a ₹2,198 crore deal.

Anupam Rasayan is taking control of Bliss GVS Pharma at ₹299 per share, triggering a mandatory open offer for an additional 26% stake.

Verify on exchange BSE filings for BLISSGVS NSE filings for BLISSGVS Tijori Finance company page